Elevated levels of brain natriuretic peptide as a predictor of impaired coronary endothelial function in patients with left ventricular remodeling

Journal of Cardiology

Volumn 48, Issue 3, 2006, Pages 125-132

  Ninomiya, Yuichi ^a   Hamasaki, Shuichi ^a   Ishida, Sanemasa ^a   Kataoka, Tetsuro ^a   Saihara, Keishi ^a   Okui, Hideki ^a   Orihara, Koji ^a   Fukudome, Tsuyoshi ^a   Shinsato, Takuro ^a   Ichiki, Tomoko ^a   Mizoguchi, Etsuko ^a   Otsuji, Yutaka ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; FEMALE; HEART VENTRICLE REMODELING; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; BIOLOGICAL MARKERS; CORONARY DISEASE; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; VASODILATION; VENTRICULAR REMODELING;

EID: 39049180811     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H: Increased human brain natriuretic peptide in congestive heart failure. NEnglJMed 1990; 323: 757-758
2. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203
3. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ : Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intra-coronary ultrasound. J Am Coll Cardiol 1995; 26: 41-49
4. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr: Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-2431
5. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A: Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 3390-3395
6. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A: Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77-81
7. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K: Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholes-terolemia. Heart 2002; 87: 264-269
8. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J: Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85: 1899-1911
9. Kataoka T, Hamasaki S, Ishida S, Saihara K, Okui H, Fukudome T, Shinsato T, Mizoguchi E, Ninomiya Y, Otsuji Y, Minagoe S, Tei C: Contribution of increased minimal coronary resistance and attenuated vascular adaptive remodeling to myocardial ischemia in patients with systemic hypertension and ventricular hypertrophy. Am J Cardiol 2004; 94: 484-487
10. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, Silverman NH, Brundage B, Botvinick EH, Boswell R, Carlsson E, Pannley WW: Left ventricular volume from paired biplane two-dimensional echocardiogra-phy. Circulation 1979; 60: 547-555
11. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977; 55: 613-618
12. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-1330
13. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci VVS, Sutton MG, Selwyn AP, Alexander RW, Ganz P: Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated car-diomyopathy. Circulation 1990; 81: 772-779
14. Mathier MA, Rose GA, Fifer MA, Miyamoto MI, Dinsmore RE, Castano HH, Dec GW, Palacios IF, Semigran MJ: Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1998; 32: 216-224
15. Yang Y, Loscalzo J: Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000; 101: 2144-2148
16. Belch JJ, Bridges AB, Scott N, Chopra M: Oxygen free radicals and congestive heart failure. Br Heart J 1991; 65: 245-248
17. Plane F, Jacobs M, McManus D, Bruckdorfer KR: Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipopro-teins. Atherosclerosis 1993; 103: 73-79
18. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH: Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 1982; 66: 342-354
19. Sonnenblick EH, Fein F, Capasso JM, Factor SM : Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am J Cardiol 1985; 55: 179B-184B
20. Kavanaugh WM, Harsh GRIV, Starksen NF, Rocco CM, Williams LT: Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. J Biol Chem 1988; 263: 8470-8472
21. Collins T, Pober JS, Gimbrone MA Jr, Hammacher A, Betsholtz C, Westermark B, Heldin CH: Cultured human endothelial cells express platelet-derived growth, factor A chain. Am J Pathol 1987; 126: 7-12
22. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ, Scarborough RM, Lewicki JA: Atrial natri-uretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 1986; 78: 1362-1374
23. Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ: Haemodynamic effects of atrial peptide infusion in heart failure. Lancet 1986; 11 : 1242-1245
24. Nakamura M, Arakawa N, Yoshida H, Makita S, Niinurna H, Hiramori K: Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J 1998; 135: 414-420
25. Waldman SA, Rapoport RM, Murad F: Atrial natriuretic factor selectively activates paniculate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 1984; 259: 14332-14334
26. Hussain MB, MacAllister RJ, Hobbs AJ: Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and paniculate guanylate cyclases. Am J Physiol Heart Circ Physiol2001; 280: H1151-H1159
27. Wennberg PW, Miller VM, Rabelink T, Burnett JC Jr: Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism. Am J Physiol 1999; 277: H1618-H1621
28. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ: Vascular natriuretic peptide receptor-linked paniculate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. BrJ Pharmacol 2003; 139: 1289-1296
29. Potter LR: Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: Dephosphorylation is a mechanism of desensitization. Biochemistry 1998; 37: 2422-2429
30. Potter LR, Garbers DL: Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J Biol Chem 1992; 267: 14531-14534
31. Zellner C, Protter AA, Ko E, Pothireddy MR, DeMarco T, Hutchinson SJ, Chou TM, Chatterjee K, Sudhir K: Coronary vasodilator effects of BNP: Mechanisms of action in coronary conductance and resistance arteries. Am J Physiol 1999; 276: H1049-H1057
32. Bauersachs J, Galuppo P, Fraccarollo D, Christ M, Ertl G: Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation 2001; 104: 982-985